Home Perfuze

Perfuze

Medtech Company Perfuze Raises €3 Million in Seed Round

“Perfuze has a technology with the potential to significantly improve outcomes for stroke patients,” says John Yianni, Partner at Earlybird. “We are delighted to offer our financial and commercial support in helping this exciting company grow and get its life-saving technology to market.”